Text dimension
Procter & Gamble received a inventory bump through the pandemic from its portfolio of cleansing merchandise. The dishwashing cleaning soap Dawn is a P&G model.
Joe Raedle/Getty Images
Procter & Gamble inventory received a little bit of a bump from the Covid-19 cleansing craze, however it has been on the dropping facet up to now this 12 months. But fiscal third-quarter numbers, due out on Tuesday morning, will probably be an opportunity to present that customers are nonetheless clamoring for the corporate’s manufacturers.
Shares of Procter & Gamble (PG) are down 1.7% 12 months to date, though they’ve climbed greater than 13% prior to now 12 months.
The consumer-products firm turned in a string of strong earnings results as customers flocked to its manufacturers, particularly these like Mr. Clean and Microban, which dovetailed with an elevated give attention to cleanliness through the pandemic.
That stated, better-than-expected earnings outcomes haven’t at all times translated into share features. And some analysts have requested how the corporate and different pandemic winners will keep their momentum going as mass vaccination reduces the specter of the virus. Rising input costs have additionally been a drag for some consumer-staples corporations, even with price increases passing on a few of these prices to customers.
P&G, nonetheless, did get a lift final week after saying a 10% increase to its dividend.
For the approaching report, analysts are in search of EPS of $1.19 on income of $17.97 billion. That compares with EPS of $1.64 and income of $19.75 billion within the prior quarter.
Just over half of the 23 analyst tracked by FactSet fee P&G a Buy or the equal, whereas 43% fee it at Hold. There is a single bearish ranking. The common worth goal is $151.84.
P&G will host a convention name at 8:30 a.m. EDT on Tuesday.
Write to Teresa Rivas at teresa.rivas@barrons.com
